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Abstract
Compartmental models have provided a framework for understanding disease
transmission dynamics for over 100 years. The predictions from these models are
often policy relevant and need to be robust to model assumptions, parameter
values and model structure. A selection of compartmental models with the same
parameter values but different model structures (ranging from simple structures
to complex ones) were compared in the absence and presence of several policy
interventions to assess sensitivity to model structure. Models were fitted to data
to assess if this might reduce this sensitivity. The compartmental models
produced wide-ranging estimates of outcome measures but when fitted to data,
the estimates obtained were robust to model structure. This finding suggests
that there may be an argument for selecting simple models over complex ones,
but the complexity of the model should be determined by the purpose of the
model and the use to which it will be put.
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Introduction
Advances in computational power have lead to mathematical modelling
being used increasingly to solve real-world problems in all ﬁelds and levels of
decision making. In epidemiology, mathematical models and in particular
compartmental models, have been used to explore (among other things) the
emergence and spread of disease, and the impact and efﬁcacy of interventions
such as drug treatment, vaccine introduction and parasite control (Murray,
2003). There is no single compartmental model structure that ﬁts all diseases
and there are many different structures that may be used to model the same
disease. The results of these models are often policy relevant and in many
cases used by policy makers to estimate populations at risk, design and
implement strategies to combat disease and monitor and evaluate on-going
interventions. In this regard, models are and should be subjected to rigorous
sensitivity testing (Chubb & Jacobsen, 2010). This testing process involves
identifying parameters that strongly inﬂuence model outcomes and testing
assumptions that when relaxed, strongly inﬂuence model results. These
model assumptions can pertain to population size and initial conditions
among other things. While sensitivity is assessed in the case of model
assumptions and parameter values, sensitivity to model structure is not often
explored, as the particular model structure is chosen in advance from a suite
of models. Studies exploring sensitivity to model structure include
Rahmandad & Sterman (2008) who compared compartmental models with
agent-based models to assess heterogeneity and network structure and Ferrer
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et al (2012) who evaluated the impact of anti-malarial
interventions on compartment and agent-based models.
Yet there may still be differences in model predictions
between compartmental models of the same disease with
equivalent parameters but different model structure. In
this regard, this paper explores the sensitivity of a selection
of epidemiologically relevant compartmental models that
differ only in model structure. While this may seem
limited, it serves to show that differences because of model
structure may not only occur between classes of models
but within them as well. In this paper this sensitivity
to model structure is assessed in a number of ways:
differences in model predictions in the implementation
of routine drug therapy, general vector control (VC), mass
drug administration and whether these predictions differ
between models if the models have been ﬁtted to data
or not. The next section provides an introduction to
compartmental models in epidemiology. The models are
developed in the section after that while the penultimate
section illustrates the results and the ﬁnal section follows
the discussion.
Compartment models in epidemiology
The ﬁrst known contribution of mathematical modelling
in epidemiology is Daniel Bernoulli’s work on the inocula-
tion against smallpox in 1760 (Brauer et al, 2008). Ross,
Halmer, Soper, Kermack and McKendrick all contributed
to the application of compartmental models to epidemiol-
ogy between 1900 and 1935 (Anderson & May, 1992). The
model proposed by Kermack and McKendrick in 1927 has
come to be known as the Susceptible-Infective-Recovered
(SIR) model with underlying equations:
dS
dt
¼ - βSI (1)
dI
dt








where t is time, S is the susceptible population (at risk of
infection), I is the infectious population (capable of trans-
mitting infection) and R is the recovered population
(removed and playing no further role in the epidemic).
β is the number of contacts per unit time and 1/α is the rate
of recovery.
This model results in a ﬁxed population N (S+I+R)where
members of the population mix homogeneously (interact
with one another to the same degree). There is no entry
into or departure from the population as the dynamics of
the disease are much faster than the time scale of birth and
death processes; and hence the impact of these processes
on the population can be ignored. Any inherent age,
demographic and spatial structure is also ignored. There is
no initial immunity as all ‘members’ of the susceptible
population are equally likely to get infected. The model
infers permanent immunity; once recovered, a second
infection is impossible. The incubation period of the
infectious agent is instantaneous and the duration of
infectivity is the same as the duration of the disease (one
is infectious as long as one has the disease). Discrete
individuals do not exist in the model and it is assumed
that individuals who reside in the compartments are
identical and as such variation among individuals is
unimportant. Thus compartmental models are described
as population-level models. It is fractions of the popula-
tion that ﬂow between compartments and these move-
ments are continuous. The rate of recovery 1/α is constant
for each ‘member’ of the population and hence the
average duration of infectiousness (and in this case dis-
ease) is α.
There are several extensions of the SIR model, including
the Susceptible-Infectious (SI) model where immunity is
ignored (by excluding the Recovered compartment), the
Susceptible-Exposed-Infectious-Recovered (SEIR) model
that allows for a period of latency/exposure before becom-
ing infectious, the Susceptible-Infectious-Recovered-
Susceptible (SIRS) model that allows for temporary immu-
nity and other similar models ( Jacquez, 1996). As diseases
have different characteristics, these models may be
extended to include biology (stages of immunity, vector/
pathogen dynamics, super-infection), demography (birth
and death processes, age, gender), interventions (drug
therapy, vaccines, VC) and geography (spatial structure,
migration). Even the same disease may be modelled with
very different structures (Figure 1). In the case of malaria,
Koella & Antia (2003) published SIRS models incorporat-
ing resistance to drug therapy and super-infection, Yang
(2000); Yang & Ferreira (2000) incorporated socio-
economic and environmental factors into SEIR models for
hosts and vectors (incorporating dynamics in an SEI model
for mosquitoes), Torres-Sorando & Rodriguez (1997)
included migration and visitation in an SIS model and
Auger et al (2008) extended the Ross-Macdonald model to
several patches in a meta-population compartmental
model (Ross, 1911; Mandal et al, 2011).
In using several different structures to model the same
disease, it is of interest to assess if there are large differences
in model predictions because of model structure alone.
This paper compares a selection of model structures and
the predicted impact of policy interventions. This paper
also explores whether ﬁtting the models to data to deter-
mine parameter values empirically, reduces sensitivity to
model structure.
Model development
Different model structures are compared for a disease that
has a latent period (L), a period where clinical symptoms
have manifested but the host is not yet infectious (B), and
an infectious period (I ) that does not grant immunity that
is, a person may be re-infected once susceptible (S) again.
These models are compared in the absence and presence of
drug therapy. Once infected and clinically ill, a patient has
the potential to receive drug therapy and those who do not
receive drug therapy recover naturally that is, they do
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not die from the disease but recover through the body’s
natural defences at a period longer than the drug recovery
period. Patients may seek drug therapy when symptoms
have manifested (they feel ill) as well as at the infectious
stage. The natural recovery period is assumed to be longer
than the drug recovery period and the time to infectious-
ness, hence natural recovery is only possible once the
disease is at the infectious stage and not any earlier. Birth
and death, super-infection and the development of immu-
nity through repeated infections are ignored. Such a
disease with a latent period and no immunity would need
to be modelled using variants of an SEIS general model
structure.
Three models are compared in the absence of drug
therapy (SLI, SBI, SLBI) and ﬁve models are compared in
the presence of drug therapy (SLI, SBI, SLBI, stratiﬁed SBI,
and stratiﬁed SLBI) (Figure 2). These models are compared
with an alternate version of the SLBI model where the
probability of receiving treatment is applied at the time of
acquiring infection rather than during the infection, as an
alternative way of capturing the proportion of infections
that are treated (Model 6 in Figure 2). This alternate SLBI
model assumes a per-infection probability of treatment
whereas the other models assume a per unit-time
probability of treatment. Differences between models are
estimated by measuring incidence and prevalence of the
disease and the treatment coverage. This alternate SLBI
model is used to simulate data for data-ﬁtting purposes so
as to assess if validating models with data through
empirical estimation of parameter values reduces the
sensitivity of the models to differences in model struc-
ture. Finally policy interventions (VC and mass drug
administration) are also modelled to assess differences in
model predictions because of model structure.
The model parameters driving these models and their
assumed values are in Table 1. All models are from the
Susceptible-Exposed-Infectious-Susceptible (SEIS) class
of models where L is used to characterise the latent phase
of the disease. In Model 1 (SLI), the latent (L) and
symptomatic (B) stages of the disease have been com-
bined; hence the rate of ﬂow between Latent compart-
ment and the Infectious compartment is 1/(σ1+σ2).
When incorporating drug therapy into the models, one
has to consider at what stage of the disease the popula-
tion has access to drug therapy. As the disease has a
latent stage, it is only in the infectious compartment that
the population may seek drug therapy and this occurs at
the rate p/(q+τ) (incorporating the treatment probability
Figure 1 Evolution and grouping of different types of SEIR malaria models. Subscripts ‘h’ and ‘m’ stands for human and mosquito.
Double-folded boxes are for both human & mosquito population, and single fold boxes are only for human. First time addition of a
new compartment is shown in grey script. The subscript ‘j’ (=1, 2, 3) indicates further subdivision of the corresponding compartment.
Three models inside the big grey box are considered as the Basic malaria models. Dotted arrows show the incorporation of complex
factors in different models or specific compartment (encircled). Total population size is constant for all models, except the ones inside
the dashed box.
Source: Mandal et al, (2011): published in Malaria Journal.
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(p), the time to seek treatment (τ) and the drug recovery
period). This rate naturally comprises two steps: treat-
ment seeking and recovery through drug therapy. As
there is no treated compartment in this model to
explicitly allow for this, the total time to move from
being infectious to becoming susceptible again is q+τ and
hence the population who receive drug therapy (with
probability p) do so at a rate of p×1/(q+τ). The population
that is infectious but remains untreated recover naturally
at the natural recovery rate ((1−p)/δ).
Models 2 (SBI) and 4 (Stratiﬁed SBI) do not have a
latent compartment, only compartments reﬂecting the
symptomatic (B) and infectious (I) stages of the disease,
where the subscripts u and t in Model 4 represent
untreated and treated infections respectively. These
models account for the latent period by including a
time delay in the force of infection (λ) of size σ1. As
symptoms have manifested (population feels ill) in the
symptomatic compartment (B), the population may
receive drug therapy from both this and the infectious
compartments. At the symptomatic stage, p% of the
population will seek and receive drug therapy (Model 2) or
seek treatment (Model 4) while (1−p)% of the population
will remain untreated and become infectious. In Model 2,
the time to seek treatment is incorporated in the
same manner as for Model 1. In Model 4, owing to the
inclusion of Symptomatic and Infectious compartments
for the treated population, the time to seek treatment
is incorporated explicitly. The latent and symptomatic stages
of the disease are captured separately in Models 3 (SLBI) and
5 (Stratiﬁed SLBI) and treatment is incorporated in the same
way as Models 2 and 4 respectively. Model 6 stratiﬁes the
population into the ‘never treated’ and those ‘destined to
be treated’ by multiplying the force of infection λ by the
treatment probability (p). Treatment can take place at
both the symptomatic and infectious compartments and
occurs at the rate 1/(q+τ) (incorporating the time to seek
treatment and time to drug recovery) while the
untreated recover naturally at the natural recovery rate
(1/δ). The equations underlying all these models are







Figure 2 Model flowcharts.; (a) Model 1: SLI (With treatment);
(b) Model 2: SBI (With treatment); (c) Model 3: SLBI (With treat-
ment); (d) Model 4: Stratified SBI (With treatment); (e) Model 5:
Stratified SLBI (With treatment); (f) Model 6: Alternate Stratified
SLBI (With treatment).
Table 1 Model parameters: Description and value
Parameter Description Value Rate of
flow




τ Time to seek
treatment
0.5 week 1/τ






0, 0.1, 0.5, 1
N Population Size 1000 people
β Contact Rate 10 per annum β
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Models are compared using steady state measures of
incidence, prevalence and treatment coverage. Incidence
is measured as the number of new cases at each time step,
prevalence is measured as the population infected with the
disease (L, B or I) at each time step and treatment coverage
is estimated by cumulative treated cases as a proportion of
cumulative cases.
Results
Models were ﬁtted to data using least squares approach
(Hansen et al, 2012) and differential equations were
solved using the linearised analytic method for ordinary
differential equations. All models were programmed in
R v3.02 (R Core Group, 2013). Model results are pre-
sented under the conditions of no treatment, treatment
at different levels, and where external anti-disease inter-
ventions are imposed on the models. These results are
contrasted between models that have been ﬁtted to data
and models that have not.
No treatment
Of the six models, only models 1, 2 and 3 are tested under
the condition of no drug treatment. This is because when
the probability of treatment (p) is 0, model 4 collapses to
model 2 andmodels 5 and 6 collapse to model 3. Under the
condition of no treatment, prevalence in the three models
is equivalent while incidence differs slightly among model
structures (Figure 3). Incidence in model 2 is higher than
models 1 and 3 because the force of infection λ is a function
of the Infectious compartment and the rate of ﬂow between
the Symptomatic and Infectious compartments is faster
than that between the Latent and Infectious compartments
in model 1. Similarly, incidence in model 3 is lower than in
models 1 and 2 as the infectious reservoir is comparatively
smaller in model 3.
With treatment
Figure 4 shows that when imposing a 10% treatment
probability on the infected population, models 1–5 predict
a higher number of treated cases than model 6 and the
treatment coverage, as measured by cumulative treated
cases as a proportion of cumulative incidence, is estimated
correctly by model 6 (10%) but overestimated by the other
5 models. A 10% probability of treatment implies a treat-
ment coverage between 34 and 39% in models 1–5. The
two stratiﬁed models (4 and 5) behave similarly in that
they have the same prevalence and treatment coverage.
Likewise models 2 and 3 behave similarly. The treatment
coverage is higher in all models compared with the model
6 because these models predict a higher number of treated
cases and lower incidence. At a 50% treatment probability
models 1–5 predict a lower number of treated cases than
model 6 and the treatment coverage is estimated correctly
by model 6 (50%) but underestimated by the other ﬁve
models (10.6–17.2%). This is because Models 1–5 also
predict that incidence and prevalence will decrease to 0,
albeit at different rates, while model 6 maintains stable
non-zero prevalence and incidence levels. At a 100%
treatment probability, all models predict a decrease in
incidence and prevalence to 0, again at varying rates, with
model 6 decreasing to 0 at the slowest rate compared to the
other models. These results are shown in the Appendices.
Treatment coverage and the probability of treatment
The results in the section ‘With treatment’ show large
differences in treatment coverage in all six models. It is
only in model 6 that the treatment coverage reﬂects the
treatment probability. Exploring why this may be so
requires understanding of how treatment coverage is
estimated mathematically. Generally values of the para-
meters that drive compartmental models may be sourced
from literature, take on assumed values or may be esti-
mated from data. In modelling the impact of drug ther-
apy, the proportion of infections that are treated
(treatment coverage in this paper) is sometimes the best
source of data available to mathematical modellers to use
to estimate the treatment probability (the chance of
receiving drug therapy) in their models. As shown in the
results, depending on the structure of the compartmental
model, these two values (treatment coverage and the
treatment probability) will not always be equal. Treat-
ment probability p is used in the models to determine the
proportion of the infected and infectious populations
that get treated and treatment coverage is estimated from
the models to determine cumulatively, the proportion of
cases that actually get treated.
In order to assess the relationship between treatment
probability (p) and treatment coverage (denoted as π),
consider a simple SIS model (S+I=1) for a cohort of
infected individuals governed by the equation:
dI
dt

































Figure 3 No treatment: Incidence and prevalence for Model 1
(solid), Model 2 (dashed) and Model 3 (dotted).
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where β is the number of contacts per unit time, p is the
probability of treatment, 1/q is the drug recovery rate and
1/δ is natural recovery rate. For ease of computation let
a= p/q+(1−p)/δ and assume initial conditions of S(0)=0
and I(0)=1.
Using the result that in an SIS model, S=1−I,
dI
dt
¼ βI 1 - Ið Þ - aI: (5)








Using the initial condition I(0)=1, this integrates to
-








I ¼ a - βð Þe
β - að Þt
a - βe β - að Þt
: (8)
The treatment coverage (π) is a function of the cumula-
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Figure 4 10% Treatment Probability: (a) Incidence; (b) Prevalence; (c) Treated Cases and (d) Treatment Coverage for Model 1 (solid),
Model 2 (dashed), Model 3 (dotted), Model 4 (dot-dash), Model 5 (long dash) and Model 6 (two dash).
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Eq. (13) will tend to a ﬁnite limit depending on the
relation between a (the average recovery rate) and β (the
transmission coefﬁcient). To establish this relation, one
can look at the dynamics of the disease when the SIS
model has reached a steady state. At equilibrium, the sum
of the inﬂows to a compartment is equal to the sum of its









Substituting a= p/q+(1−p)/δ and S=1−I into Eq. (14)
leads to
βI 1 - Ið Þ ¼ aI (15)
This simpliﬁes to
I ¼ β - a
β
: (16)
This system has two equilibria:
1. The trivial (infection-free) equilibrium
2. The non-trivial equilibrium where infection is present
Both equilibria exist depending on the relationship
between β and a. If β<a, the trivial equilibrium is stable
but if β> a then the non-trivial equilibrium, the equili-
brium where infection is present is non-negative and
stable.





- qa a - βð Þ ´
a - β
β
ae a - βð Þt - β




- qa a - βð Þ ´
a - β
β











  : (20)
Thus for an SIS model, treatment coverage (π) is not
equal to the treatment probability (p), but rather a func-
tion of the p, δ and q.
This result holds for Model 1 but will change for
models with different structures (Models 2–5). The results
in the section ‘With treatment’ showed that treatment
coverage in Model 6 correctly represented the 10%


























q + τ B + Ið Þ
λS
: (25)
Treatment coverage (π) at equilibrium is treated cases
((B+I)/(q+τ)) as a proportion of incidence (λS) and hence for
Model 6, π= p. Thus while treatment coverage data is often
used by modellers as the best estimate of treatment prob-
ability, depending on the model structure, the treatment
coverage predicted by the model may be very different
from the treatment probability.
Data ﬁtting
Showing that for different model structures, treatment
coverage is not always equal to treatment probability,
demonstrates that even for routine anti-disease interven-
tions like drug therapy, model structure has a large impact
on model results. This section explores if ﬁtting models to
data reduces this sensitivity to model structure that is, if
models are ﬁtted to data, does model structure matter less
or at all? Model 6 is used to simulate the number of treated
cases for data ﬁtting purposes as this was the only one of
the six models where p= π. Many national health systems
collect routine data on cases that are treated so this would
be typical of data available to mathematical modellers. It is
not usually the case that true incidence data would be
available as the untreated infected population is generally
hidden from the health system. The treated cases from all
ﬁve models are ﬁtted to the model 6 data estimating the
value of p (0.1 in the model 6). All other parameter values
are held constant at their assumed values in Table 1.
Parameter estimation is achieved using the Least Squares
algorithm for data ﬁtting. All ﬁve models ﬁt the data well
with the estimated value of p, the probability of being
treated, being in the range of 0.0063–0.0097. At these
values of p, the six models make identical predictions for
prevalence, treated cases and treatment coverage with only
small differences observed in the prediction of incidence,
thereby showing the decrease in sensitivity to model
structure that can be achieved by ﬁtting models to data.
Impact of other interventions
Compartment and other models of disease transmission
may be used to assess the impact of policy interventions
on transmission. Two interventions are applied to the
184
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six models to assess sensitivity because of model struc-
ture; mass drug administration and VC. These inter-
ventions are then scaled up, aimed at eliminating the
disease.
Mass drug administration Mass drug administration
involves administering drug therapy to the population
at risk regardless of disease status (Greenwood, 2010). An
example of this intervention is reﬂected in the models
by an increase in the treatment probability p. Mass drug
administration is implemented over 8 weeks at 75%
probability in all models. The graphs on the left in Figure
5 show the impact of this intervention on models that
have not been ﬁtted to data while the graphs on the right
show the impact this intervention has on the models
once they were ﬁtted to the data from model 6. The
results show that when mass drug administration is
applied to the ﬁtted models, all models reach the same
equilibrium before the intervention and show an
increase in the number treated at the time of the
intervention but revert to the previous equilibrium
eventually, whereas models that were not ﬁtted to data
reached different points of equilibrium. Even though
the ﬁtted models achieve the same pre- and post-inter-
vention equilibrium, the immediate impact (decrease in
incidence and prevalence) of the intervention varies
between model structures.
Vector control In some diseases like malaria and dengue,
vectors are an active part of disease transmission. VC as an
intervention, requires acting on the vector population in a
way that interrupts transmission. This may for example be
achieved through larviciding, the use of insecticide
treated bednets and household spraying with pesticides
(World Health Organization, 1997). In models 1–6, this
intervention is captured as having a decreasing effect on β;
the number of contacts with vectors. The coverage of the
control as well as the efﬁcacy of process are taken
into account in decreasing β where βVC= (1−cover-
age*efﬁcacy)*β. In these models an example of VC is







































































































Figure 5 Mass Drug Administration (8 weeks, 75% probability of treatment). (a & b) Incidence; (c & d) Prevalence; (e & f) Treated
Cases and (g & h) Treatment Coverage for Model 1(solid), Model 2 (dashed), Model 3 (dotted), Model 4 (dot-dash), Model 5 (long
dash) and Model 6 (two dash).
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introduced into the models with 50% coverage and 50%
efﬁcacy. Figure 6 (left) shows that the different model
structures (not ﬁtted to data) measure the impact of VC
very differently; some showing a much greater impact on
prevalence and incidence than others. Once the models
have been ﬁtted to data however, these differences are
minimal (Figure 6 (right)).
Modelling to disease elimination When interventions are
used to eliminate a disease rather than attempt to control
it, mathematical models will aim to produce estimates of
the length of time to eliminate the disease, the intensity
of each of intervention as well as the combinations of
interventions that may be used to eliminate a disease.
Elimination of infection is deﬁned as the reduction to 0 of
locally acquired incidence in a geographical area as the
result of deliberate efforts (Dowdle, 1998). Two very
resource-intensive interventions aimed at eliminating a
disease are tested on the six models: VC with a 90%
coverage and at a 90% efﬁcacy and a scaling up of drug
therapy from a 10% treatment probability to a 90% treat-
ment probability. As the compartments and hence the
ﬂows between compartments will never actually reach 0
to achieve elimination as outlined above, the disease is
assumed to be eliminated when prevalence decreases
below 10−6. The impact of these interventions is esti-
mated as the time to elimination (in weeks) from the start
of the interventions. These interventions are tested on
the six models that have not been ﬁtted to data and on
the models once they have been ﬁtted to data.
Table 2 shows that by scaling up VC, the models that are
not ﬁtted to data predict widely varying time to elimina-
tion values ranging from 193 weeks (<4 years) to 458
weeks (<9 years). When ﬁtted to data the predictions fall
in a narrower range between 416 and 458 weeks. The
results are quite different for a drug scale up intervention.
When ﬁtting the models to data, p, the probability of
treatment, is the estimated parameter from the data-ﬁtting
process. Thus when uniformly increasing the p to 0.9 at
the start of the intervention, the previously ﬁtted value
falls away and hence the time to elimination estimates are








































































































Figure 6 Vector control (50% Coverage, 50% Efficacy): (a & b) Incidence; (c & d) Prevalence; (e & f) Treated Cases and (g & h) Treat-
ment Coverage for Model 1 (solid), Model 2 (dashed), Model 3 (dotted), Model 4 (dot-dash), Model 5 (long dash) and Model 6 (two
dash).
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the same regardless of whether the models are ﬁtted or not.
These estimates range widely from 50 weeks (<1 year) to
399 weeks (<8 years) depending on the model structure.
These estimates are not robust and clearly sensitive to
model structure.
Discussion
As mathematical modelling is increasingly used to aid
decision making in the public health sector models need
to be rigorously tested for sensitivity to parameter values
and model assumptions so that model predictions are
robust (Chubb & Jacobsen, 2010). Incorporating the
standard intervention of drug therapy produced very
different results for all models tested in terms of preva-
lence, incidence and the treatment coverage. With only
a 10% treatment probability, the decrease in prevalence
of the disease ranges between 3 and 49%. At higher
treatment rates (> 50%), the disease was even eliminated
in some models. These differences occurred for models
with the same parameter values and model assumptions
but different model structures. The practical signiﬁcance
of these differences is great in that reducing a disease
marginally (3%) or reducing a disease by half have very
different impacts on a public health sector with minimal
scarce resources and high opportunity cost on these
resources. This is reiterated by groups such as the Mal-
ERA Consultative Group on Modelling, who recognised
the contribution modelling can make to the elimination
of malaria globally and developed a framework of prior-
ity areas for modelling to inform such as optimal
resource allocation and expected timelines to achieve
goals (The malERA Consultative Group on Modeling,
2011). Model results need to be robust to model structure
if they are to play a role in informing strategy and policy
design, where scarce resources will be committed on the
basis of the models’ predictions.
Fitting the ﬁve models to data simulated from model 6
(to empirically estimate the treatment probability),
shows that the sensitivity because of model structure
can be reduced. As countries become better at collecting
routine data and performing clinical trials, opportunities
exist for modellers to validate their models with real
data. Data quality issues aside, modellers may still be
able to use their models to reproduce the data, as well
as validate model predictions with a testing dataset. As
models are extended to incorporate speciﬁc disease
dynamics such as immunity (Aron, 1988; Yang &
Ferreira, 2000; Smith et al, 2006), vector populations
(Dietz, 1980; Luz et al, 2010) and geography (Brauer,
2001; Juan, 2006; Tumwiine et al, 2010), different model
structures may well produce very different results and
predictions. Fitting models to data where possible can
reduce the sensitivity of the model results to model
structure.
In attempting to eliminate the disease using VC, it was
found that ﬁtting the models to data decreased the
sensitivity to model structure, but this was not the case
for drug scale-up. The varying predictions on time to
eliminate the disease can be partly explained by the
treatment seeking behaviour deﬁned in each model. In
model 1, the population only has one chance at receiv-
ing drug therapy (Infectious compartment), whereas in
models 2 and 3, the population has two chances to
receive drug therapy (Symptomatic and Infectious com-
partments) and hence it is harder to eliminate the disease
in model 1 than in models 2 and 3. The longest time to
elimination estimate is from model 6 (the alternate
stratiﬁed SLBI). In this model, a segment of the popula-
tion has no chance to receive drug therapy in the course
of the infection and will have to wait until the next
round of infections to stand a chance of receiving drug
therapy. In this case, it is much harder to eliminate the
disease. Modellers should be aware of the treatment-
seeking behaviour of the populations they model, but
where this information is not available, there is an
argument for modelling different treatment-seeking
behaviours so that this heterogeneity may be better
understood and prudent and conservative estimates
may be produced. O’Connell et al (2012) found in their
study of malaria in Cambodia that treatment-seeking
behaviour is complex, often driven by cultural norms
and other practicalities.
Some of the models in this paper have a simple
structure while others have more complex structures.
The results have shown that models seeking to measure
the same phenomenon (e.g. estimating the impact of
drug therapy) that differ in structure only, can produce
very similar results if they are ﬁtted to the same set of data.
Does the argument exist for choosing simple models
over complex ones? The answer is yes, but the converse
is also true. On one extreme one could have a model that
is too simple to be biologically plausible and on the
other extreme, the most biologically plausible model
may be too complex to be of any practical use. There
needs to be a balance between model simplicity and
biological plausibility for models to be of practical
relevance. White et al (2009) compared the results of a
simple deterministic compartmental model with other
agent-based stochastic complex models in a malaria-
elimination context. They concluded that in situations
where data is sparse, yet urgency exists to provide input
Table 2 Time to elimination (weeks) for vector control
and scale-up of drug therapy
Time to Elimination (weeks) Vector Control Drug Scale-up
Not Fitted Fitted Not Fitted Fitted
Model 1 206 416 120 120
Model 2 193 424 50 50
Model 3 197 426 54 54
Model 4 260 432 121 121
Model 5 266 434 241 241
Model 6 458 458 399 399
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into strategy design, simple model structures are suitable
but complex models can provide more information (on
the context being modelled), especially in the long term.
This paper sought to compare results between determi-
nistic compartmental models only and did not extend to
include other model structures such as agent-based models
and time series models. While this is a limitation of the
paper, it also serves to show that differences in results
because of model structure arise not only among different
classes of models but among models in the same class also.
Several aspects have been ignored such as immunity, super
infection, chemoprophylaxis, drug resistance, heterogene-
ity of the population and vector population dynamics.
Stochasticity was also ignored. It was not in the scope of
the paper to include all aspects of disease, but rather to
show that even in the most basic disease context, differ-
ences still exist because of model structure. These are all
areas where further work can be undertaken. Ultimately,
model structure (and its complexity) needs to be chosen
carefully depending on the focus of the model and the use
to which it will be put.
Compartmental model structures are based on the
underlying epidemiological and demographic interac-
tions of a particular disease. Given that there are many
choices for these interactions, the number of possible
combinations are large (Hethcote, 1994). This manu-
script is one of few to compare a selection of these
models to assess their similarities and differences. The
primary contribution of this paper is to show that not all
models are equal. Differences exist even with the smal-
lest changes in model structure and increases in com-
plexity of models may result in different conclusions
being drawn from the model predictions. Gaining a clear
understanding of these models enables one to choose a
structure that is suitable to the epidemiological process
being modelled. Additionally the paper shows that ﬁtting
models to data can reduce the differences because of
model structure, but even so offers limited assistance
once models are used for predictions. One purpose of a
mathematical model is to simulate a current epidemiolo-
gical situation for the purposes of testing potential policy
interventions to assess their impact on the disease. This
often requires expanding on the existing model structure
to accommodate these interventions. As interventions
may be modelled in many ways, differences in model
predictions may still result because of differences in
structure only. This is often not considered. Fitting
models to data will assist with simulating the current
epidemiological situation, but not with the predictions
on the proposed policy interventions. These model pre-
dictions can be made robust by introducing stochasticity
into the model to produce a range of plausible predic-
tions. Second, the interventions themselves should be
modelled in a set of different structures to assess the range
in predictions and gain an understanding of the impact
that the chosen model structure has on the output.
Ultimately, mathematical models will not all produce
the same results and thus an in depth understanding of
the model structure is necessary to maximise the useful-
ness of these models.
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Model 4 (Stratiﬁed SBI)
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Model 5 (Stratiﬁed SLBI)
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Model 6 (Alternate Stratiﬁed SLBI)
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Figure B1 50% Treatment Probability. (a) Incidence; (b) Prevalence; (c) Treated Cases and (d) Treatment Coverage for Model 1
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Figure B2 100% Treatment Probability. (a) Incidence; (b) Prevalence; (c) Treated Cases and (d) Treatment Coverage for Model 1
(solid), Model 2 (dashed), Model 3 (dotted), Model 4 (dot-dash), Model 5 (long dash) and Model 6 (two dash).
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